Rocket


Overview
Financials
News + Filings
Key Docs
Ownership

 
 

Erytech Pharma S.A. (ERYP) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15
Revenues-26.6-15.6-7.8
            Revenue growth70.5%98.6% 
Cost of goods sold0.00.0-15.5
Gross profit-26.6-15.67.6
            Gross margin100.0%100.0%-97.2%
General and administrative10.66.87.7
EBIT-37.1-22.4-15.6
            EBIT margin139.8%143.7%198.6%
Pre-tax income-40.3-21.9-15.0
Income taxes0.00.00.0
            Tax rate 0.0% 
Net income-40.3-21.9-15.0
            Net margin151.7%140.6%191.3%
 
Diluted EPS($3.54)($2.74)($2.16)
Shares outstanding (diluted)11.48.07.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy